These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38610554)
41. Prediction of breast cancer risk with volatile biomarkers in breath. Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019 [TBL] [Abstract][Full Text] [Related]
42. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD. Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437 [TBL] [Abstract][Full Text] [Related]
43. Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study. Gashimova E; Temerdashev A; Perunov D; Porkhanov V; Polyakov I Mol Diagn Ther; 2024 Nov; 28(6):847-860. PubMed ID: 39299985 [TBL] [Abstract][Full Text] [Related]
44. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711 [TBL] [Abstract][Full Text] [Related]
45. Noninvasive detection of lung cancer by analysis of exhaled breath. Bajtarevic A; Ager C; Pienz M; Klieber M; Schwarz K; Ligor M; Ligor T; Filipiak W; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Haidenberger A; Buszewski B; Miekisch W; Schubert J; Amann A BMC Cancer; 2009 Sep; 9():348. PubMed ID: 19788722 [TBL] [Abstract][Full Text] [Related]
46. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
47. Volatile organic compounds as new biomarkers for colorectal cancer: a review. Di Lena M; Porcelli F; Altomare DF Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703 [TBL] [Abstract][Full Text] [Related]
48. Breath analysis by mass spectrometry: a new tool for breast cancer detection? Patterson SG; Bayer CW; Hendry RJ; Sellers N; Lee KS; Vidakovic B; Mizaikoff B; Gabram-Mendola SG Am Surg; 2011 Jun; 77(6):747-51. PubMed ID: 21679645 [TBL] [Abstract][Full Text] [Related]
49. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis. van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079 [TBL] [Abstract][Full Text] [Related]
50. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966 [TBL] [Abstract][Full Text] [Related]
51. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns. Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896 [TBL] [Abstract][Full Text] [Related]
52. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: A prospective cohort study. Zhang Y; Guo L; Qiu Z; Lv Y; Chen G; Li E J Clin Lab Anal; 2020 Dec; 34(12):e23526. PubMed ID: 33150682 [TBL] [Abstract][Full Text] [Related]
53. Detection of Four Distinct Volatile Indicators of Colorectal Cancer using Functionalized Titania Nanotubular Arrays. Bhattacharyya D; Kumar P; Mohanty SK; Smith YR; Misra M Sensors (Basel); 2017 Aug; 17(8):. PubMed ID: 28777343 [TBL] [Abstract][Full Text] [Related]
54. Exhaled breath analysis for the diagnosis and assessment of endoluminal gastrointestinal diseases. Markar SR; Wiggins T; Kumar S; Hanna GB J Clin Gastroenterol; 2015 Jan; 49(1):1-8. PubMed ID: 25319742 [TBL] [Abstract][Full Text] [Related]
55. Rapid breath analysis for acute respiratory distress syndrome diagnostics using a portable two-dimensional gas chromatography device. Zhou M; Sharma R; Zhu H; Li Z; Li J; Wang S; Bisco E; Massey J; Pennington A; Sjoding M; Dickson RP; Park P; Hyzy R; Napolitano L; Gillies CE; Ward KR; Fan X Anal Bioanal Chem; 2019 Sep; 411(24):6435-6447. PubMed ID: 31367803 [TBL] [Abstract][Full Text] [Related]
56. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children. Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575 [TBL] [Abstract][Full Text] [Related]
57. Breath analysis of smokers, non-smokers, and e-cigarette users. Papaefstathiou E; Stylianou M; Andreou C; Agapiou A J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122349. PubMed ID: 32920481 [TBL] [Abstract][Full Text] [Related]
58. Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients. Bouza M; Gonzalez-Soto J; Pereiro R; de Vicente JC; Sanz-Medel A J Breath Res; 2017 Mar; 11(1):016015. PubMed ID: 28165332 [TBL] [Abstract][Full Text] [Related]
59. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study. Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453 [TBL] [Abstract][Full Text] [Related]
60. Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable? Di Gilio A; Palmisani J; Picciariello A; Zambonin C; Aresta A; De Vietro N; Franchini SA; Ventrella G; Nisi MR; Licen S; Barbieri P; Altomare DF; de Gennaro G J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37379826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]